Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1998 | 12-1997 | 09-1997 | 06-1997 | 03-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,010 | -23,875 | -7,825 | -6,920 | -4,089 |
| Depreciation Amortization | 830 | 3,244 | 2,392 | 1,567 | 789 |
| Other Working Capital | 1,030 | 1,809 | -1,370 | -281 | -836 |
| Other Operating Activity | 380 | 11,181 | -880 | -984 | 0 |
| Operating Cash Flow | $-1,770 | $-7,641 | $-7,683 | $-6,618 | $-4,136 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -660 | -4,565 | -2,646 | -1,899 | -842 |
| Other Investing Activity | 15,030 | -67,572 | -38,178 | -46,382 | -8,812 |
| Investing Cash Flow | $14,370 | $-72,137 | $-40,824 | $-48,281 | $-9,654 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 2,730 | 74,903 | -71,332 | 69,718 | 69,485 |
| Financing Cash Flow | $2,730 | $74,903 | $-71,332 | $69,718 | $69,485 |
| Beginning Cash Position | 9,260 | 14,141 | 14,141 | 14,141 | 14,141 |
| End Cash Position | 24,590 | 9,266 | 36,966 | 28,960 | 69,836 |
| Net Cash Flow | $15,330 | $-4,875 | $22,825 | $14,819 | $55,695 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,770 | -7,641 | -7,683 | -6,618 | -4,136 |
| Free Cash Flow | -1,770 | -7,641 | -7,683 | -6,618 | -4,136 |